Assessment of 3M Oedema Reduction System in the Treatment of Lymphoedema Compared to Commercial Short-stretch Bandage

Inclusion Criteria (Arm): * Mobile males or females, age 18 years or older * Unilateral arm lymphoedema of secondary origin * Pitting arm lymphoedema diagnosed as stage II or late stage II according to the International Society of Lymphology staging * Patients who require intense bandaging therapy (approx. \>= 15% increase in arm volume over the opposite healthy arm) * Completion of all primary and adjuvant cancer treatments (surgery, chemotherapy, radiotherapy) at least 6 months prior to randomisation * Willing to give written informed consent and willing to comply with the study protocol Inclusion Criteria (Leg): * Mobile males or females, age 18 years or older * Unilateral or bilateral leg lymphoedema of primary or secondary origin * Pitting leg lymphoedema diagnosed as stage II or late stage II according to the International Society of Lymphology staging * Patients who require intense bandaging therapy * Completion of all primary and adjuvant cancer treatments (surgery, chemotherapy, radiotherapy) at least 6 months prior to randomisation * Willing to give written informed consent and willing to comply with the study protocol Exclusion Criteria (Arm): * Known pregnancy * Evidence of active cancer, either local or metastatic * A period of intense daily bandaging within the last month * Decompensated heart failure or clinically relevant kidney or liver disease * Known relevant arterial disease of the arms * Deep vein thrombosis or phlebitis in the last 3 months * Paralysis of the arms * Clinical infection of the arms (e.g. erysipelas) * Wounds located at the study arm that require dressing change more than once a week * History of allergic reactions to study material * Participation in any prospective clinical study that can potentially interfere with this study * Participants who are, in the opinion of the clinical investigator, unsuitable for enrolment in this study, for reasons not specified in the exclusion criteria. Exclusion Criteria (Leg): * Known pregnancy * Evidence of active cancer, either local or metastatic * A period of intense daily bandaging within the last month * Decompensated heart failure or clinically relevant kidney or liver disease * Deep vein thrombosis or phlebitis in the last 3 months * Known relevant arterial disease of the legs * Paralysis of the legs * Clinical infection of the legs (e.g. erysipelas) * Circumferential Lymphorrhoea * Wounds located at the study leg that require dressing change more than once a week * History of allergic reactions to study material * Participation in any prospective clinical study that can potentially interfere with this study * Participants who are, in the opinion of the clinical investigator, unsuitable for enrolment in this study, for reasons not specified in the exclusion criteria.